Search research articles
Contact Us
Filters
Showing results (61-70 of 166) with videos related to
Page
of 17
Sort By:
British Medical Bulletin
|
October 24, 2015
Clinical trial transparency: many gains but access to evidence for new medicines remains imperfect
Barbara Mintzes, Joel Lexchin, Ancella Santos Quintano
The New Zealand Medical Journal
|
May 11, 2023
Time for New Zealand to ban direct-to-consumer advertising of prescription medicines
David B Menkes, Barbara Mintzes, Joel Lexchin
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
September 4, 2003
Direct-to-consumer prescription drug advertising in Canada: permission by default?
David M Gardner, Barbara Mintzes, Aleck Ostry
Journal of Women'S Health (2002)
|
March 17, 2020
A Cohort Study of Psychotropic Prescription Drug Use in Pregnancy in British Columbia, Canada from 1997 to 2010
Gillian E Hanley, Tarita Miller, Barbara Mintzes
BMJ Evidence-Based Medicine
|
May 16, 2024
Direct-to-consumer advertising: a modifiable driver of overdiagnosis and overtreatment
David B Menkes, Barbara Mintzes, Joel Lexchin
Science and Engineering Ethics
|
May 4, 2018
Medicines Information and the Regulation of the Promotion of Pharmaceuticals
Teresa Leonardo Alves, Joel Lexchin, Barbara Mintzes
British Journal of Clinical Pharmacology
|
July 1, 2017
Unwarranted claims of drug efficacy in pharmaceutical sales visits: are drugs approved on the basis of surrogate outcomes promoted appropriately?
Roojin Habibi, Joel Lexchin, Barbara Mintzes, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
March 23, 2011
Antidepressants and pregnancy
Barbara Mintzes, Elia Abi-Jaoude, Anne Rochon Ford
Regional Anesthesia and Pain Medicine
|
May 29, 2026
Methodological limitations and conflicts of interest in spinal cord stimulation research impair trustworthiness
Joanna Diong, Kamila Navarro, Adrian Traeger, et al.
BMJ (Clinical Research Ed.)
|
May 28, 2025
Self-regulation of UK's pharmaceutical industry
Piotr Ozieranski, Shai Mulinari, Cinzia Colombo, et al.
Page
of 17
Search research articles
Search
Showing results (61-70 of 166) with videos related to
Sort By:
Page
of 17
British Medical Bulletin
|
October 24, 2015
Clinical trial transparency: many gains but access to evidence for new medicines remains imperfect
Barbara Mintzes, Joel Lexchin, Ancella Santos Quintano
The New Zealand Medical Journal
|
May 11, 2023
Time for New Zealand to ban direct-to-consumer advertising of prescription medicines
David B Menkes, Barbara Mintzes, Joel Lexchin
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
September 4, 2003
Direct-to-consumer prescription drug advertising in Canada: permission by default?
David M Gardner, Barbara Mintzes, Aleck Ostry
Journal of Women'S Health (2002)
|
March 17, 2020
A Cohort Study of Psychotropic Prescription Drug Use in Pregnancy in British Columbia, Canada from 1997 to 2010
Gillian E Hanley, Tarita Miller, Barbara Mintzes
BMJ Evidence-Based Medicine
|
May 16, 2024
Direct-to-consumer advertising: a modifiable driver of overdiagnosis and overtreatment
David B Menkes, Barbara Mintzes, Joel Lexchin
Science and Engineering Ethics
|
May 4, 2018
Medicines Information and the Regulation of the Promotion of Pharmaceuticals
Teresa Leonardo Alves, Joel Lexchin, Barbara Mintzes
British Journal of Clinical Pharmacology
|
July 1, 2017
Unwarranted claims of drug efficacy in pharmaceutical sales visits: are drugs approved on the basis of surrogate outcomes promoted appropriately?
Roojin Habibi, Joel Lexchin, Barbara Mintzes, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
March 23, 2011
Antidepressants and pregnancy
Barbara Mintzes, Elia Abi-Jaoude, Anne Rochon Ford
Regional Anesthesia and Pain Medicine
|
May 29, 2026
Methodological limitations and conflicts of interest in spinal cord stimulation research impair trustworthiness
Joanna Diong, Kamila Navarro, Adrian Traeger, et al.
BMJ (Clinical Research Ed.)
|
May 28, 2025
Self-regulation of UK's pharmaceutical industry
Piotr Ozieranski, Shai Mulinari, Cinzia Colombo, et al.
Page
of 17